Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1991-04-12
1992-12-08
Cintins, Marianne M.
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
1286534, A61B 5055, C07D48722, G01N 2408
Patent
active
051699443
ABSTRACT:
Hepatobiliary magnetic resonance imaging of a human or animal subject is enhanced by enterally administering to the subject an effective amount of a lipophilic contrast enhancing agent. Representative contrast enhancing agents include manganese mesoporphyrin, manganese deuteroporphyrin, manganese pheophorbide and manganese pyrophenophoribide, and, when administered orally, an enteric delivery agent.
REFERENCES:
patent: 4393071 (1983-07-01), Fujii et al.
patent: 4656186 (1987-04-01), Bommer
patent: 4797392 (1989-01-01), Chernomorsky
patent: 4804529 (1989-02-01), Bardy et al.
patent: 4877872 (1989-10-01), Morgan et al.
patent: 4899755 (1990-02-01), Lauffer et al.
patent: 5051415 (1991-09-01), Morgan et al.
patent: 5053423 (1991-10-01), Liu
Fawwaz, R. et al., "Use of Metalloporphyrins in Diagnostic Imaging," Nucl. Med. Biol. 17(1):65-72, 1990.
Fiel, R. J. et al., "A Comparative Study of Manganese meso-Sulfonatophenyl Porphyrins: Contrast-Enhancing Agents for Tumors," Magnetic Resonance Imaging 8:255-259, 1990.
Jackson, L. S. et al., "Manganese Protoporphyrin IX; A Potential Intravenous Paramagnetic NMR Contrast Agent: Preliminary Communication," Investigative Radiology, Mar.-Apr. 1985, vol. 20, No. 2, J. B. Lippincott Co. publishers, pp. 226-229.
Nelson, J. A. et al., "Kinetic Studies of Manganese Mesoporphyrin," Contrast Agents in MR Imaging, 1986, Range, Claussen, Felix, James editors, pp. 74-75.
Cegnar, J. M. et al., "Adsorption of Lipophilic Contrast Agent with Cholestyramine," poster presentation, Association of University Radiologists, 1987.
Place, D. A. et al., "Metalloporphyrins as Contrast Agents for Tumors in MRI," abstract M24 from meeting of Oct. 8-13, 1989 of Contrast Media Research held at Sydney and Hamilton Island, Australia.
Nelson, J. A. et al., "Metalloporphyrins as Tumor Seeking MRI Contrast Media and as Potential Selective Treatment Sensitizers," abstract from meeting of Oct. 8-13, 1989 of Contrast Media Research held at Sydney and Hamilton Island, Australia.
Nelson, J. A. et al., "Metalloporphyrins as Tumor Seeking MRI Contrast Media as Potential Selective Treatment Sensitizers," Invest. Radiol 25:571-573, 1990.
Rose, I. S. et al., "Effect of Ingestion of Hemoproteins on Fecal Excretion of Hemes and Porphyrins," Clinical Chemistry 35(12):2290-2296, 1989.
Bohdiewicz, P. J. et al., "Mn (III) Hematoporphyrin: A Potential MR Contrast Agent," Investigative Radiology 25:765-797, 1990.
Cory, D. A. et al., "Ingested Manganese Chloride as a Contrast Agent for Magnetic Resonance Imaging," Magnetic Resonance Imaging 1986.
Vreman, H. J. et al., "Effects of Oral Administration of Tin and Zinc Protoporphyrin on Neonatal and Adult Rat Tissue Heme Oxygenase Activity," Journal of Pediatric Gastroenterology and Nutrition 7:902-906, 1988.
Unger, E. C. et al., "Hepatic Metastases: Lipsomal Gd-DTPA-enhanced MR Imaging," Radiology 171:81-85, 1989.
Young, S. W. et al., "Detection of Hepatic Malignancies Using Mn-DPDP (Manganese Dipyridoxal Diphosphate) Hepatobiliary MRI Contrast Agent," Magnetic Resonance Imaging 8:267-276, 1990.
Anderson, K. E. et al., "Disposition of tin-protoporphyrin and Suppression of Hyperbilirubinemia in Humans," Clin. Pharmacol. Ther. 39(5):510-519, 1985.
Iwai, K. et al., "Tumor Uptake of [.sup.48 V]Vanadyl-Chlorine e.sub.6 Na as a Tumor-imaging Agent in Tumor-bearing Mice," Nucl. Med. Biol. 178(8):775-780, 1990.
Nelson, J. A. et al., "Manganese Mesoporphyrin: Hepatobiliary MRI Contrast Characteristics," presented at Aug. 8-24, 1990 meeting of Society of Magnetic Resonance in Medicine, New York.
Bommer Jerry C.
Nelson James A.
Schmiedl Udo P.
Teng Lin-nar L.
Board of Regents of the University of Washington
Cintins Marianne M.
Hydorn Michael B.
LandOfFree
Methods and compositions for the enteral administration of hepat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for the enteral administration of hepat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for the enteral administration of hepat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-961801